What Are Wall Street Analysts' Target Price for Labcorp Holdings Stock?

Burlington, North Carolina-based Labcorp Holdings Inc. (LH) provides laboratory services that aid doctors, hospitals, pharmaceutical companies, researchers, and patients. Valued at a market capitalization of $21.3 billion, it operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. LH offers various tests, including blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA tests, and tests for sexually transmitted diseases, among others.

LH shares have lagged behind the broader market over the past year, surged 7.4% compared to the S&P 500 Index ($SPX) 27.9% surge. Moreover, in 2026, the stock has grown nearly 3.6%, underperforming the SPX’s 9.2% rise as well.